Exercise training and heparin pretreatment in patients with coronary artery disease.
The purpose of this study was to evaluate whether combined treatment with a cardiovascular exercise rehabilitation program and low doses of heparin can induce changes in ergometric parameters of ischemia in patients with coronary artery disease (CAD). Heparin may potentiate the development of new vessels promoted by ischemia and therefore may produce important clinical improvement. Thirty-six patients with stable CAD and evidence of myocardial ischemia on exercise testing were randomized into three groups: a control group (n = 11) received the usual medical treatment; another group (n = 11) underwent three exercise sessions per week during 12 weeks; and a third group (n = 14) undertook this exercise program and also received calcium heparin 12,500 IU subcutaneously 20 to 30 minutes before each exercise session. Pretreatment and posttreatment exercise tests were compared. Patients who underwent the rehabilitation program had an increase in exercise duration and workload at the onset of 1 mm ST-segment depression, but only patients who received calcium heparin showed a significant increase in rate-pressure product at the ST-segment ischemic threshold (p = 0.035). This result suggests that higher levels of myocardial oxygen consumption were now tolerated, a change that may be related to an improvement in myocardial perfusion.
Division of Cardiology, Hospital Municipal Dr. Cosme Argerich, Buenos Aires, Argentina.
J A
JA
Gagliardi
N G
NG
Prado
J C
JC
Marino
S
S
Lederer
A O
AO
Ramos
C A
CA
Bertolasi
D003327:Coronary Disease / Q000188:drug therapy / Q000503:physiopathology / Q000534:rehabilitation / Q000628:therapy*; D005081:Exercise Therapy; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010101:Oxygen Consumption; D016896:Treatment Outcome
D005343:Fibrinolytic Agents; C006871:calcium heparin; D006493:Heparin